Sonoma Pharmaceuticals, Inc. (SNOA) — Institutional Holders, Q2 2026

14 institutional investment managers reported a SNOA position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $136.3K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

SNOA in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

4

Added to

1

Trimmed

1

Sold out

6

Biggest buyers

  1. RENAISSANCE TECHNOLOGIESNew · +40,468 sh+$49.8K
  2. UBS Group AGNew · +7,808 sh+$9.6K
  3. GEODE CAPITAL MANAGEMENTAdded · +6,846 sh+$8.4K
  4. BARCLAYS PLCNew · +459 sh+$565.00
  5. HARBOUR INVESTMENTSNew · +15 sh+$18.00

Biggest sellers

  1. DRW SecuritiesSold out · -12,015 sh-$14.8K
  2. CITIGROUPSold out · -1,425 sh-$1.8K
  3. Tower Research Capital (TRC)Sold out · -1,231 sh-$1.5K
  4. JPMORGAN CHASESold out · -123 sh-$151.00
  5. US BANCORP \DE\Sold out · -25 sh-$31.00

SNOA 13F holders ranked 1–14 of 14

Institutional investors reporting a position in Sonoma Pharmaceuticals, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
RENAISSANCE TECHNOLOGIES#1 · 40,468 sh$49.8KNew
GEODE CAPITAL MANAGEMENT#2 · 26,787 sh$32.9K+34.3%
VANGUARD CAPITAL MANAGEMENT#3 · 18,787 sh$23.1K0.0%
McKinley Carter Wealth Services#4 · 11,193 sh$13.8K0.0%
UBS Group AG#5 · 7,808 sh$9.6KNew
Global Retirement Partners#6 · 2,548 sh$3.1K—
MORGAN STANLEY#7 · 2,000 sh$2.5K-0.2%
OSAIC#8 · 500 sh$615.000.0%
BARCLAYS PLC#9 · 459 sh$565.00New
BlackRock#10 · 113 sh$139.000.0%
VANGUARD FIDUCIARY#11 · 100 sh$123.000.0%
HARBOUR INVESTMENTS#12 · 15 sh$18.00New
Quaker Wealth Management#13 · 3 sh$4.000.0%
DANSKE BANK A/S#14 · 1 sh$1.000.0%

Funds that sold out of SNOA in Q2 2026 (6)

Held SNOA at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held SNOA in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
DRW Securities12,015 sh$25.6K
CITIGROUP1,425 sh$3.0K
Tower Research Capital (TRC)1,231 sh$2.6K
JPMORGAN CHASE123 sh$255.00
US BANCORP \DE\25 sh$53.00
Caitong International Asset Management , Ltd1 sh$2.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.